Market Overview

Benzinga's Top Downgrades

Related BAX
UPDATE: Baxter Posts Upbeat Q3 Earnings, Issues Weak Earnings Forecast
Earnings Scheduled For October 16, 2014
Merck Snags Baxter Executive As CFO (Fox Business)
Related CVC
Benzinga Weekly Preview: Retail In Focus
UPDATE: Cablevision Q3 Earnings Beat Estimates
J-Lo-Backed Network Outbids 'Diddy' for Fuse (Fox Business)

Analysts at Mizuho downgraded Baxter International (NYSE: BAX) from “buy” to “neutral.” Baxter's shares closed at $66.84 yesterday. Baxter's trailing-twelve-month profit margin is 16.36%.

Analysts at Canaccord downgraded Cablevision Systems (NYSE: CVC) from “buy” to “hold.” Cablevision's shares closed at $14.02 yesterday. Cablevision's trailing-twelve-month ROA is 9.77%.

Analysts at RBC Capital downgraded McMoRan Exploration Co (NYSE: MMR) from “outperform” to “sector perform.” McMoRan Exploration's shares closed at $9.65 yesterday. McMoRan Exploration's PEG ratio is -4.48.

Bernstein downgraded Boston Scientific (NYSE: BSX) from “outperform” to “market perform.” Boston Scientific's shares closed at $5.66 yesterday. Boston Scientific's trailing-twelve-month ROE is -43.84%.

Latest Ratings for BAX

DateFirmActionFromTo
Oct 2014BarclaysMaintainsOverweight
Oct 2014Credit SuisseMaintainsOutperform
Oct 2014Morgan StanleyMaintainsEqual-weight

View More Analyst Ratings for BAX
View the Latest Analyst Ratings

Posted-In: Top DowngradesDowngrades Analyst Ratings

 

Related Articles (BAX + BSX)

Around the Web, We're Loving...

Get Benzinga's Newsletters